{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "27cea28a-1afe-46f5-94b9-e6ca6d3d3958", "code": "N03AX11", "comments": "ATC|NERVOUS SYSTEM|ANTIEPILEPTICS|ANTIEPILEPTICS|Other antiepileptics|topiramate", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N03AX11&showdescription=yes", "code_system": "WHO-ATC", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "b6f4ff97-690a-4c32-be51-c624c8b25f2f", "code": "N0000175753", "comments": "Established Pharmacologic Class [EPC]|Anti-epileptic Agent [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175753", "code_system": "NDF-RT", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "b2ad8d5a-f01d-4ad1-ae0b-e9b1edb1df6e", "code": "N0000008486", "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Electrical Activity Alteration [PE]|Disorganized Electrical Activity Alteration [PE]|Decreased Disorganized Electrical Activity [PE]|Decreased Central Nervous System Disorganized Electrical Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008486", "code_system": "NDF-RT", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "bb3eb383-cac6-4629-9b73-72d6a2abeec7", "code": "QN03AX11", "comments": "VATC|ANTIEPILEPTICS|ANTIEPILEPTICS|Other antiepileptics|topiramate", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN03AX11&showdescription=yes", "code_system": "WHO-VATC", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "1299e650-8606-4348-8e26-9dd4f0364b73", "code": "97240-79-4", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=97240-79-4", "code_system": "CAS", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29", "e8767e05-93fc-45e5-9da2-65336f3a5868" ] }, { "uuid": "d7498be1-c86c-477f-98e7-a6df60cfb3c5", "code": "NBK548632", "comments": "LiverTox|CNS|Anticonvulsant|Miscellaneous", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548632/", "code_system": "LIVERTOX", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "cd64f8aa-95cc-4422-87b2-c0a2b5dab78e", "code": "C052342", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/67052342", "code_system": "MESH", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "2ff2e301-6eee-40cd-b8a6-21fbc12e660b", "code": "TOPIRAMATE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Topiramate", "code_system": "WIKIPEDIA", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "da7786c6-ae6a-448b-b51c-5968b2ea6b97", "code": "SUB11190MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "a0c6059d-c144-4fa2-bd92-a1f38b0dd67c", "code": "6099", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=6099", "code_system": "INN", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "fb8340cb-d06a-4a19-aff3-9601156c746d", "code": "QSIVA (REFUSED: OBESITY)", "comments": "EMA EPAR|ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT|DIAGNOSIS|DIAGNOSIS TECHNIQUES AND PROCEDURES|PHYSICAL EXAMINATION|ANTHROPOMETRY|BODY WEIGHTS AND MEASURES|BODY SIZE|BODY WEIGHT|OVERWEIGHT|OBESITY", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002350/human_med_001607.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "6da2ca81-d885-46c1-a98a-edfd8cd0ba9d", "code": "6849", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6849", "code_system": "IUPHAR", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "c1646576-5a2c-4f9a-9fbd-04d0cdc59bd8", "code": "C47764", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47764", "code_system": "NCI_THESAURUS", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "d220af9c-7cf9-4942-897a-38ae7b2824ed", "code": "38404", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/38404/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "4c341ffd-b2c6-4f5c-b876-022e1827ccb6", "code": "m10976", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m10976?q=authorize", "code_system": "MERCK INDEX", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "f68b0a44-03ca-4a19-80b4-ff78d8dbc96c", "code": "DB00273", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00273", "code_system": "DRUG BANK", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "33050098-f5af-4ecd-b78f-c34a65b9bcf4", "code": "CHEMBL220492", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "code_system": "ChEMBL", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "0cef299e-8b24-4490-9c52-c8ded7cfa568", "code": "N0000182140", "comments": "Cytochrome P450 2C19 Inhibitors [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000182140", "code_system": "NDF-RT", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "8bedc8f7-ab24-4e73-bf7f-bacff8f24390", "code": "N0000185506", "comments": "Cytochrome P450 3A4 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000185506", "code_system": "NDF-RT", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "af2d4271-65aa-4b53-b892-e472ac664b60", "code": "5284627", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284627", "code_system": "PUBCHEM", "references": [ "500129f6-3816-4905-8832-fe1bbb061b29" ] }, { "uuid": "1c4f7395-e2ab-1200-fd1c-d7ac0ee8e4c5", "code": "7531", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7531", "code_system": "HSDB", "references": [ "e9b3260c-dd3e-2c8b-6058-36e0354f1c7f" ] }, { "uuid": "a4f00558-1063-2f5b-52ce-90f96329e156", "code": "DTXSID8023688", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID8023688", "code_system": "EPA CompTox", "references": [ "052890dd-bde9-d2af-5116-1057f061b134" ] }, { "uuid": "ebfc0468-281e-518d-f96d-291686764434", "code": "70792", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of Lennox-Gastaut syndrome.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=70792", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "8eedca88-d8fe-884b-802c-d439cd5a49e4", "code": "283909", "comments": "ORPHAN DRUG|Designated|Treatment of partial onset or primary generalized tonic-clonic seizures for hospitalized epilepsy patients or epilepsy patients being treated in an emergency care setting who are unable to take oral topiramate", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=283909", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "25d859d2-ce91-31ef-90e2-c971fddeb00e", "code": "C264", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anticonvulsant Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C264", "code_system": "NCI_THESAURUS", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "2e869cf8-566e-4868-9eca-dcfd078499d6", "code": "0H73WJJ391", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "32379d73-25e4-e869-538d-7285bd0ca7f2", "code": "Topiramate", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM390/", "code_system": "LACTMED", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "1f544ae4-1dae-fac8-fcf1-7a8820c9143d", "code": "2706", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/2706", "code_system": "DRUG CENTRAL", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "3a63fa3b-a3a7-bb7e-f540-57036acb0d29", "code": "1672206", "type": "PRIMARY", "url": "https://store.usp.org/product/1672206", "code_system": "RS_ITEM_NUM", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "32e8ef61-1612-ac13-1706-d13c8b5e9acd", "code": "63631", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:63631", "code_system": "CHEBI", "references": [ "06b1bf29-2143-b172-d88f-ab3fb7f321a8" ] }, { "uuid": "191defae-59fe-282c-34b2-79949af0d39f", "code": "Y-25", "type": "PRIMARY", "url": "https://searchusan.ama-assn.org/finder/usan/search/Y-25/relevant/1/", "code_system": "USAN", "references": [ "847af886-4c3b-aa7f-c9d0-344655668157" ] }, { "uuid": "6b242d39-3d3d-c5b3-370f-1265ad0a7f76", "code": "0H73WJJ391", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=0H73WJJ391", "code_system": "DAILYMED", "references": [ "b8d82e8b-c982-b489-2275-5a1aa27209a3" ] }, { "uuid": "68a6e895-3441-6f8c-937f-abb985378fb2", "code": "100000092536", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "404e6bdf-4d9a-af3d-fbae-985cef38e532" ] } ], "substance_class": "chemical", "references": [ { "uuid": "76debfc4-7a19-74a6-2a24-1c39634ebb0c", "citation": "Britzi, Malka, et al. \"Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography–mass spectrometry assay.\" Therapeutic drug monitoring 25.3 (2003): 314-322.", "url": "https://insights.ovid.com/crossref?an=00007691-200306000-00012", "doc_type": "JA", "public_domain": true }, { "uuid": "6d8f3b56-e5c6-43ab-8b10-74001d30070f", "citation": "https://www.drugbank.ca/drugs/DB00273", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "dc07ba7d-00c5-4a10-a637-4ed70ae85e82", "citation": "https://www.drugbank.ca/drugs/DB00273", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "da810387-6b12-419d-b146-bd0e8f7c1a36", "citation": "https://www.drugbank.ca/drugs/DB00273", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "c41fc1ec-8a29-4312-bcd5-ba6b48490201", "citation": "https://www.drugbank.ca/drugs/DB00273", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "40dd6dcf-6c44-47b6-99fd-613e029d4f32", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "387ebfff-7711-430c-b34c-934eb3e01a41", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c74d1930-eac6-45cc-98f2-003ae64b979f", "citation": "INN Proposed List 57", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL57.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "85ec5475-9ff8-4cf3-b4fc-0ca288e87dbc", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9637a2c2-38cd-4b12-8a33-61c91a9bab87", "citation": "KEGG 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "338d2b97-f9ac-4a7f-a848-3fc4546a4084", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0c05fe07-5be5-45aa-8551-f2e1a774473b", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "494c2191-ca51-4591-8735-4183945e10e3", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c6aca7ee-8f13-4301-b091-bccdf2f1ce41", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "54dceda7-569f-4635-9916-fddc3585a2df", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "89e8dc4a-43c6-4a11-bc76-ce2c8b111ac7", "citation": "http://www.qsymia.com/pdf/full-prescribing-information.pdf", "url": "http://www.qsymia.com/pdf/full-prescribing-information.pdf", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9952addd-e6f7-442c-9673-799055c60e2f", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "174deea3-431a-4b11-bb07-4fdde6cae2ae", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7daf8743-993f-43d6-873d-bc77473bac71", "citation": "PCPC", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4e4052c3-d8ec-4bf9-a717-f25bd3a10b10", "citation": "MERCK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "54bc4452-6fa8-4383-baf0-6b174a64347e", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "dc3d30e7-d4e3-42af-9669-4d4012f0957c", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a1789411-9790-4e69-bf53-d789d0555faf", "citation": "CLINICAL TRIALS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "54de6174-e96d-4490-ac55-d9a8f6ff4b74", "citation": "http://www.upsher-smith.com/wp-content/uploads/Content-of-Labeling-QUDEXY-XR-FPI-Med-Guide.pdf", "url": "http://www.upsher-smith.com/wp-content/uploads/Content-of-Labeling-QUDEXY-XR-FPI-Med-Guide.pdf", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "cbcccddc-6648-4401-b06c-f53ae7827b4b", "citation": "USP DICTIONARY", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "500129f6-3816-4905-8832-fe1bbb061b29", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389684000, "tags": [ "NOMEN" ] }, { "uuid": "801b91ce-63ef-49dd-ba3d-505c38502b92", "citation": "USP 36 TOPIRAMATE MONOGRAPH", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9b03bb7e-f7a1-4df6-9029-13fe20c2ec73", "citation": "EPILEPSIU, 41(SUPPL. I):S61-S65, 2000", "url": "http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1157.2000.tb02174.x/pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1a787ecd-9a62-400c-b832-5ae560000aa8", "citation": "SRS import [0H73WJJ391]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0H73WJJ391", "doc_type": "SRS", "public_domain": true, "document_date": 1493389684000, "tags": [ "NOMEN" ] }, { "uuid": "b89ebfba-9ed0-4b4a-a80f-a7cef02e36d4", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0166dd4a-0b3e-41a2-9e33-41cd082e35d7", "citation": "TOPIRAMATE [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c32bbb40-412d-4368-8da0-88acf23f341c", "citation": "TOPIRAMATE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "83653033-3e24-493a-b140-626c061f27f6", "citation": "TOPIRAMATE [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "3c40f96c-1836-4682-baee-5831fc336a0b", "citation": "TOPIRAMATE [JAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "731ac2a4-db72-4e73-b49a-d56219fe4149", "citation": "TOPIRAMATE [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "d2811f30-cb17-47e0-bc36-4e0a98728007", "citation": "TOPIRAMATE [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "7693c44c-fbeb-4543-9a5c-382b314fdc2d", "citation": "TOPIRAMATE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "1bcd103f-f87a-46df-b7e3-617a1e21f3a8", "citation": "TOPIRAMATE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "2801b21e-ff1e-4805-9d42-742c5e163172", "citation": "TOPIRAMATE [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "eb7ac401-8106-45a3-9e0b-bcf8be195bd1", "citation": "TOPIRAMATE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e6e84407-ce41-4bb0-a557-aaa348597c23", "citation": "TOPIRAMATE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "1caf7945-322f-4298-a0fb-bff2953876e6", "citation": "TOPIRAMATE [INCI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e9b3260c-dd3e-2c8b-6058-36e0354f1c7f", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+97240-79-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "052890dd-bde9-d2af-5116-1057f061b134", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=97240-79-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "acfc9c1c-4335-58b2-5a49-24d727cf4478", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+97240-79-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "404e6bdf-4d9a-af3d-fbae-985cef38e532", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "06b1bf29-2143-b172-d88f-ab3fb7f321a8", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "1ec019fc-34d2-c0e6-e9b9-2efaacf4230d", "citation": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f686676-8d66-4f29-966c-0a31e2eee90c", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "e8767e05-93fc-45e5-9da2-65336f3a5868", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "847af886-4c3b-aa7f-c9d0-344655668157", "citation": "USAD COUN", "doc_type": "USANCOUN", "public_domain": true }, { "uuid": "e485989e-e4a6-3c2a-99fb-a44f5ce67862", "citation": "USP42-NF37 - 4394, Topiramate Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "92b27ab1-e5dd-0473-7392-64f946e5a023", "citation": "USP-RS", "doc_type": "USPNF", "public_domain": true }, { "uuid": "ec60c919-0053-5cac-76af-31fb6233a0c6", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "9434d303-acff-cf36-2ade-10b4215f1a43", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "1ced2e13-7cdf-ad96-7e85-d9f9802efbd0", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "c89df9f3-edfb-3ac7-8359-2a11eb8f854d", "citation": "DRUGS", "doc_type": "DRUGS@FDA", "public_domain": true }, { "uuid": "048a0345-8907-4899-a469-1129562ab3c0", "citation": "Shank, Richard P., Virginia L. Smith-Swintosky, and Bruce E. Maryanoff. \"Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate.\" Journal of Enzyme Inhibition and Medicinal Chemistry 23.2 (2008): 271-276.", "url": "https://www.tandfonline.com/doi/full/10.1080/14756360701507001", "doc_type": "JA", "public_domain": true }, { "uuid": "e010726c-a5c4-41c9-6863-073c65692bf3", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "fe4b05a4-bb16-48cb-9381-d7d7d5efff4b", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "b8d82e8b-c982-b489-2275-5a1aa27209a3", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "0e2353a2-f8f7-4bdc-ad6a-bbf9e593750e", "id": "0e2353a2-f8f7-4bdc-ad6a-bbf9e593750e", "molfile": "\n Marvin 01132100582D \n\n 22 24 0 0 1 0 999 V2000\n 0.9409 -1.5070 0.0000 C 0 0 2 0 0 0 0 0 0 1 0 0\n 1.3416 -0.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1636 -0.7858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.5849 -1.5148 0.0000 C 0 0 1 0 0 0 0 0 0 2 0 0\n 3.2725 -1.0728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.2363 -0.2508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9420 0.2068 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9032 1.0133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1200 0.4808 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 4.6089 0.1447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.3837 -1.6621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5465 -2.4272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.4202 -2.1713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8024 -3.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.7219 -2.8227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1584 -2.2178 0.0000 C 0 0 1 0 0 0 0 0 0 2 0 0\n 1.3571 -2.2334 0.0000 C 0 0 2 0 0 0 0 0 0 1 0 0\n 0.8013 -2.8460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0646 -2.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.7522 -2.3368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.1990 -3.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.1344 -1.6854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 1 17 1 0 0 0 0\n 1 22 1 6 0 0 0\n 2 3 1 0 0 0 0\n 4 3 1 0 0 0 0\n 4 5 1 6 0 0 0\n 4 11 1 0 0 0 0\n 16 4 1 0 0 0 0\n 6 5 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 7 2 0 0 0 0\n 10 7 2 0 0 0 0\n 12 11 1 0 0 0 0\n 13 12 1 0 0 0 0\n 14 12 1 0 0 0 0\n 15 12 1 0 0 0 0\n 16 15 1 1 0 0 0\n 17 16 1 0 0 0 0\n 17 18 1 6 0 0 0\n 19 18 1 0 0 0 0\n 20 19 1 0 0 0 0\n 21 19 1 0 0 0 0\n 19 22 1 0 0 0 0\nM END", "smiles": "CC1(C)O[C@@H]2CO[C@]3(COS(=O)(=O)N)[C@H]([C@@H]2O1)OC(C)(C)O3", "formula": "C12H21NO8S", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "63c69cc4-bd9c-43bc-8426-406106811f97" }, "defined_stereo": 4, "ez_centers": 0, "molecular_weight": "339.3636", "optical_activity": "UNSPECIFIED", "stereo_centers": 4 } ], "definition_level": "COMPLETE", "uuid": "f413079b-3bf0-415f-a3ad-c0fc03b58864", "version": "61", "structure": { "id": "07a172ec-7b2a-4ed3-863f-4a6ffc524a38", "molfile": "\n Marvin 01132100402D \n\n 25 27 0 0 1 0 999 V2000\n 2.5849 -1.5148 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 2.1584 -2.2178 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 1.3571 -2.2334 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 3.9420 0.2068 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0\n 3.3837 -1.6621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.7219 -2.8227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.9409 -1.5070 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 3.5465 -2.4272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.8013 -2.8460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0646 -2.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.1344 -1.6854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1636 -0.7858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.2725 -1.0728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.2363 -0.2508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.3416 -0.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1200 0.4808 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 4.6089 0.1447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9032 1.0133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 4.4202 -2.1713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8024 -3.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.7522 -2.3368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.1990 -3.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.3519 -3.0735 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 0.5273 -0.7936 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1584 -3.0398 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 2 1 0 0 0 0\n 4 14 1 0 0 0 0\n 5 1 1 0 0 0 0\n 6 2 1 0 0 0 0\n 7 15 1 0 0 0 0\n 8 5 1 0 0 0 0\n 9 3 1 0 0 0 0\n 10 9 1 0 0 0 0\n 11 7 1 0 0 0 0\n 12 1 1 0 0 0 0\n 1 13 1 6 0 0 0\n 14 13 1 0 0 0 0\n 15 12 1 0 0 0 0\n 16 4 2 0 0 0 0\n 17 4 2 0 0 0 0\n 18 4 1 0 0 0 0\n 19 8 1 0 0 0 0\n 20 8 1 0 0 0 0\n 21 10 1 0 0 0 0\n 22 10 1 0 0 0 0\n 3 23 1 1 0 0 0\n 7 24 1 1 0 0 0\n 2 25 1 6 0 0 0\n 6 8 1 0 0 0 0\n 3 7 1 0 0 0 0\n 10 11 1 0 0 0 0\nM END", "smiles": "CC1(C)O[C@]2([H])CO[C@]3(COS(=O)(=O)N)[C@]([H])([C@]2([H])O1)OC(C)(C)O3", "formula": "C12H21NO8S", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 4, "ez_centers": 0, "molecular_weight": "339.3636", "optical_activity": "UNSPECIFIED", "references": [ "1a787ecd-9a62-400c-b832-5ae560000aa8", "b89ebfba-9ed0-4b4a-a80f-a7cef02e36d4", "c74d1930-eac6-45cc-98f2-003ae64b979f" ], "stereo_centers": 4 }, "unii": "0H73WJJ391", "relationships": [ { "uuid": "bf8b96b6-d912-45e8-91e0-9f28e6cba1ec", "amount": { "uuid": "305377e6-dc07-46ce-9a98-5252dac9ab03" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "4fc5a31e-0df7-42a9-95b5-322764224b55", "refuuid": "f413079b-3bf0-415f-a3ad-c0fc03b58864", "name": "TOPIRAMATE", "unii": "0H73WJJ391", "linking_id": "0H73WJJ391", "ref_pname": "TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "35b7491b-d49b-42fb-8d33-3a4cf3f2d6bd", "amount": { "uuid": "959c884d-d0ba-415e-b80a-b85af305c6cf", "units": "PERCENT PEAK AREA", "high_limit": 0.3 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "801b91ce-63ef-49dd-ba3d-505c38502b92", "e485989e-e4a6-3c2a-99fb-a44f5ce67862" ], "related_substance": { "uuid": "620696f4-5d9c-4036-a179-e9239961cf40", "refuuid": "8bc6d565-773f-4e28-85ba-9f1776e4c0af", "name": "2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE", "unii": "SQ9F5005S8", "linking_id": "SQ9F5005S8", "ref_pname": "2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE", "substance_class": "reference" } }, { "uuid": "e59d48a3-4ca1-4b58-938b-40dfb48d3441", "amount": { "uuid": "f22be30a-581d-446c-8cd6-3e69ee3f2be4", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 102, "low_limit": 98 }, "qualification": "USP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (HPLC)", "references": [ "801b91ce-63ef-49dd-ba3d-505c38502b92" ], "related_substance": { "uuid": "eb4744e2-222a-4faf-ac4f-c01a51a663ef", "refuuid": "f413079b-3bf0-415f-a3ad-c0fc03b58864", "name": "TOPIRAMATE", "unii": "0H73WJJ391", "linking_id": "0H73WJJ391", "ref_pname": "TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "175852c9-e797-4365-979c-5873633ad019", "amount": { "uuid": "530ff8c2-2415-46da-8440-bf55c77059a2" }, "type": "METABOLIC ENZYME->INHIBITOR", "references": [ "9b03bb7e-f7a1-4df6-9029-13fe20c2ec73" ], "related_substance": { "uuid": "96d9131f-e746-423f-be8f-91f5478bef95", "refuuid": "4f746c19-0e0a-447a-beda-d28b91d6f23e", "name": "CYTOCHROME P450 2C19", "unii": "081I12ZA58", "linking_id": "081I12ZA58", "ref_pname": "CYTOCHROME P450 2C19", "substance_class": "reference" } }, { "uuid": "3295b0b8-3e4b-42a4-b70a-8645a642b963", "amount": { "uuid": "46583c5f-6a82-4f1c-b060-4053effb5e2d", "high": 41, "low": 15, "units": "%" }, "comments": "decreases as concentration increases", "type": "BINDER->LIGAND", "interaction_type": "BINDING", "references": [ "1ec019fc-34d2-c0e6-e9b9-2efaacf4230d" ], "related_substance": { "uuid": "dc66aae0-22c1-4771-9f9d-a7acd97d309f", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "f341e9a7-8f38-4bec-b0fe-deb6b4148396", "amount": { "uuid": "52a044f1-d986-438e-87cf-b25dc5c8790b", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "average": 70, "units": "%" }, "qualification": "URINE", "type": "EXCRETED UNCHANGED", "references": [ "1ec019fc-34d2-c0e6-e9b9-2efaacf4230d" ], "related_substance": { "uuid": "dd79d5f2-9d67-4865-9c0f-71baa894c75b", "refuuid": "f413079b-3bf0-415f-a3ad-c0fc03b58864", "name": "TOPIRAMATE", "unii": "0H73WJJ391", "linking_id": "0H73WJJ391", "ref_pname": "TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "41ee4d12-582b-4b81-9a0e-508ee633aeb6", "amount": { "uuid": "fcf18f28-5df3-471c-b5a2-f31ebfd92874" }, "type": "TARGET->AGONIST", "references": [ "6d8f3b56-e5c6-43ab-8b10-74001d30070f" ], "related_substance": { "uuid": "92c02c7f-269a-43ae-bca7-8c4f521c439c", "refuuid": "4cf6118f-ea36-401a-81df-ff093423a431", "name": "GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1", "unii": "FUG1HPD3DP", "linking_id": "FUG1HPD3DP", "ref_pname": "GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1" } }, { "uuid": "8c4cc696-13f2-48d6-97ef-640a03ab6a3c", "amount": { "uuid": "7c1b0bcd-7d4f-4fff-8b86-f9dd50fa5af7" }, "type": "TARGET->INHIBITOR", "related_substance": { "uuid": "8fb4299e-94ae-493d-85de-1d3951f43beb", "refuuid": "7ce8de6e-75b5-474a-ba0c-8e96fc932a03", "name": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA", "unii": "PIV978KC1N", "linking_id": "PIV978KC1N", "ref_pname": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA" } }, { "uuid": "f9eb4fd2-fcf0-48bc-be11-2072de58fd2a", "amount": { "uuid": "34d91d8d-7685-4277-96c9-0caca0675a32", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "average": 0.2, "units": "%" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "76debfc4-7a19-74a6-2a24-1c39634ebb0c" ], "related_substance": { "uuid": "bc05d778-7c92-4592-be7e-5c2b1f4ba598", "refuuid": "47bd294a-75a8-4029-8711-5eac1c4a7987", "name": "4,5-DESISOPROPYLIDENE TOPIRAMATE", "unii": "0KP2WFO28K", "linking_id": "0KP2WFO28K", "ref_pname": "4,5-DESISOPROPYLIDENE TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "c9414105-b31d-45e6-adfb-a1cef12e701a", "amount": { "uuid": "ce427364-7ddc-4000-b8ae-7dfb72f2273c", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "average": 5, "units": "%" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "76debfc4-7a19-74a6-2a24-1c39634ebb0c" ], "related_substance": { "uuid": "1bcd1d7c-ec12-4d5f-aa96-772e138c96d4", "refuuid": "4fb45b45-1179-14bb-2d00-1fcb8a81c082", "name": "2,3-DESISOPROPYLIDENE TOPIRAMATE", "unii": "SFN8AL5KYK", "linking_id": "SFN8AL5KYK", "ref_pname": "2,3-DESISOPROPYLIDENE TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "806080b0-e73f-4dc2-9ba6-d5c7e8ec6a85", "amount": { "uuid": "79950498-8a15-4611-be7a-d6c27a83320f", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "average": 1.2, "units": "%" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "76debfc4-7a19-74a6-2a24-1c39634ebb0c" ], "related_substance": { "uuid": "73351aef-d434-4a62-97f1-66c1c384aa65", "refuuid": "735820e8-c60d-4b1c-91c6-b70731dba8e2", "name": "S-HYDROXY TOPIRAMATE", "unii": "S8RVF7MS5R", "linking_id": "S8RVF7MS5R", "ref_pname": "S-HYDROXY TOPIRAMATE", "substance_class": "reference" } }, { "uuid": "7c74e4c7-2a5c-4a81-a006-af385d071023", "amount": { "uuid": "b217e806-67f8-48eb-b6be-e9b755ac70e5", "average": 0.45, "high": 0.53, "low": 0.38, "units": "MICROMOLAR" }, "comments": "Believed to be responsible for adverse events.", "qualification": "Ki", "type": "OFF-TARGET->INHIBITOR", "references": [ "c41fc1ec-8a29-4312-bcd5-ba6b48490201", "048a0345-8907-4899-a469-1129562ab3c0" ], "related_substance": { "uuid": "85e69dd7-00c7-427c-a16a-24ed9e847847", "refuuid": "6549bd5b-1b28-43f7-aeb0-a029c26271f8", "name": "CARBONIC ANHYDRASE 2", "unii": "C11I0OB162", "linking_id": "C11I0OB162", "ref_pname": "CARBONIC ANHYDRASE 2" } }, { "uuid": "8e7c2e02-348a-4e1b-aa84-8d7a3eae6fe3", "amount": { "uuid": "f66ce12d-4ffe-4955-813f-9e543a600e4b" }, "type": "OFF-TARGET->INHIBITOR", "references": [ "da810387-6b12-419d-b146-bd0e8f7c1a36" ], "related_substance": { "uuid": "285edbeb-ca58-4c76-9628-e003d178376d", "refuuid": "fb3e2c9d-05c1-430e-853c-8279709d4fc4", "name": "CARBONIC ANHYDRASE 4", "unii": "I5N61W32BT", "linking_id": "I5N61W32BT", "ref_pname": "CARBONIC ANHYDRASE 4" } }, { "uuid": "bcb12914-0901-4344-a2ea-bbdfc0ce9790", "amount": { "uuid": "60418a68-a5d3-470a-9264-6ce8581d0b0b" }, "type": "SALT/SOLVATE->PARENT", "references": [ "fe4b05a4-bb16-48cb-9381-d7d7d5efff4b" ], "related_substance": { "uuid": "da5f258c-25eb-45f1-b5ed-bf3e7268df53", "refuuid": "2c5da719-2bd8-4799-b260-912fe46b84d3", "name": "TOPIRAMATE SODIUM TRIHYDRATE", "unii": "3P5S0PG688", "linking_id": "3P5S0PG688", "ref_pname": "TOPIRAMATE SODIUM TRIHYDRATE", "substance_class": "reference" } } ], "names": [ { "uuid": "db121645-6445-4955-88f4-22a71d14ce84", "name": "(-)-TOPIRAMATE", "stdName": "(-)-TOPIRAMATE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dc3d30e7-d4e3-42af-9669-4d4012f0957c" ], "display_name": false }, { "uuid": "a03dcda4-cf7d-4d37-89a4-36b0bba7305e", "name": ".BETA.-D-FRUCTOPYRANOSE, 2,3:4,5-BIS-O-(1-METHYLETHYLIDENE)-, SULFAMATE", "stdName": ".BETA.-D-FRUCTOPYRANOSE, 2,3:4,5-BIS-O-(1-METHYLETHYLIDENE)-, SULFAMATE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "40dd6dcf-6c44-47b6-99fd-613e029d4f32" ], "display_name": false }, { "uuid": "f1364673-3f27-47db-9bc8-122a2a61577c", "name": "2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE SULFAMATE", "stdName": "2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE SULFAMATE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "40dd6dcf-6c44-47b6-99fd-613e029d4f32" ], "display_name": false }, { "uuid": "44613a5f-092d-4a4d-9aa1-e541e06e0582", "name": "EPITOMA", "stdName": "EPITOMA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "533eca2a-75df-42a8-a527-7d27f0e5e1e2", "name": "EPITOMAX", "stdName": "EPITOMAX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "b4608127-25bc-0432-6701-d40bc6b42cbc", "name": "EPRONTIA", "stdName": "EPRONTIA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "c89df9f3-edfb-3ac7-8359-2a11eb8f854d" ], "display_name": false }, { "uuid": "c4ae63d7-bc64-4417-ac81-35527fadc002", "name": "MCN-4853", "stdName": "MCN-4853", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "cbcccddc-6648-4401-b06c-f53ae7827b4b" ], "display_name": false }, { "uuid": "cccc58dd-b335-4b52-8531-12e7bd15a458", "name": "QSYMIA COMPONENT TOPIRAMATE", "stdName": "QSYMIA COMPONENT TOPIRAMATE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "89e8dc4a-43c6-4a11-bc76-ce2c8b111ac7" ], "display_name": false }, { "uuid": "3517cc23-6967-41e8-b5f1-8a2c65e69c8c", "name": "QUDEXY", "stdName": "QUDEXY", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54de6174-e96d-4490-ac55-d9a8f6ff4b74" ], "display_name": false }, { "uuid": "cc59ab73-9bb3-43e7-890b-28deb77d2bab", "name": "RWJ-17021", "stdName": "RWJ-17021", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "cbcccddc-6648-4401-b06c-f53ae7827b4b" ], "display_name": false }, { "uuid": "b4cf2592-b216-4164-b829-5ed9ba006927", "name": "RWJ-17021-000", "stdName": "RWJ-17021-000", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "4e4052c3-d8ec-4bf9-a717-f25bd3a10b10" ], "display_name": false }, { "uuid": "5559cb15-26df-4022-9084-4ea5e4bc2c35", "name": "SINCRONIL", "stdName": "SINCRONIL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "fa60d70b-6954-4ef8-a815-657792e41e2d", "name": "TOPAMAC", "stdName": "TOPAMAC", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "162aa191-3520-4143-968e-caea3f1c4264", "name": "TOPAMAX", "stdName": "TOPAMAX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "40dd6dcf-6c44-47b6-99fd-613e029d4f32" ], "display_name": false }, { "uuid": "4da5cb15-a722-441d-b4f2-4bd31616c556", "name": "TOPIMAX", "stdName": "TOPIMAX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "0e4fff64-47e1-4bc4-8368-675998d05418", "name": "TOPINA", "stdName": "TOPINA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "5e60718b-acba-491d-9634-a6d144f79062", "name": "TOPIRAMATE", "stdName": "TOPIRAMATE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "731ac2a4-db72-4e73-b49a-d56219fe4149", "9952addd-e6f7-442c-9673-799055c60e2f", "eb7ac401-8106-45a3-9e0b-bcf8be195bd1", "7693c44c-fbeb-4543-9a5c-382b314fdc2d", "e6e84407-ce41-4bb0-a557-aaa348597c23", "c32bbb40-412d-4368-8da0-88acf23f341c", "54dceda7-569f-4635-9916-fddc3585a2df", "0c05fe07-5be5-45aa-8551-f2e1a774473b", "2801b21e-ff1e-4805-9d42-742c5e163172", "40dd6dcf-6c44-47b6-99fd-613e029d4f32", "c6aca7ee-8f13-4301-b091-bccdf2f1ce41", "494c2191-ca51-4591-8735-4183945e10e3", "338d2b97-f9ac-4a7f-a848-3fc4546a4084", "d2811f30-cb17-47e0-bc36-4e0a98728007", "1bcd103f-f87a-46df-b7e3-617a1e21f3a8", "83653033-3e24-493a-b140-626c061f27f6", "85ec5475-9ff8-4cf3-b4fc-0ca288e87dbc", "387ebfff-7711-430c-b34c-934eb3e01a41", "1caf7945-322f-4298-a0fb-bff2953876e6", "7daf8743-993f-43d6-873d-bc77473bac71", "3c40f96c-1836-4682-baee-5831fc336a0b", "0166dd4a-0b3e-41a2-9e33-41cd082e35d7", "9637a2c2-38cd-4b12-8a33-61c91a9bab87", "174deea3-431a-4b11-bb07-4fdde6cae2ae", "c74d1930-eac6-45cc-98f2-003ae64b979f" ], "display_name": true, "domains": [ "drug", "cosmetic" ], "name_orgs": [ { "uuid": "46cc67d8-dc12-4581-8d08-1ab0aaa7f3e9", "name_org": "USAN" }, { "uuid": "087fb945-57d3-4d76-bb08-99d10c145083", "name_org": "INN" }, { "uuid": "6afebf11-3ae9-45f7-bde8-52d72ac49f61", "name_org": "INCI" } ] }, { "uuid": "43e8b6d9-345f-1bea-461e-084443cf0d71", "name": "TOPIRAMATE [EP MONOGRAPH]", "stdName": "TOPIRAMATE [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9434d303-acff-cf36-2ade-10b4215f1a43" ], "display_name": false }, { "uuid": "a62bac89-deec-4923-859c-09281628fe25", "name": "TOPIRAMATE [HSDB]", "stdName": "TOPIRAMATE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c6aca7ee-8f13-4301-b091-bccdf2f1ce41" ], "display_name": false }, { "uuid": "1c54f23c-a02b-4aed-b68f-01c850432f91", "name": "TOPIRAMATE [JAN]", "stdName": "TOPIRAMATE [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9637a2c2-38cd-4b12-8a33-61c91a9bab87" ], "display_name": false }, { "uuid": "7571133d-107f-42cb-86be-5ca31d39ef82", "name": "TOPIRAMATE [MART.]", "stdName": "TOPIRAMATE [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0c05fe07-5be5-45aa-8551-f2e1a774473b" ], "display_name": false }, { "uuid": "7df27371-f266-40f5-acde-2b037b263795", "name": "TOPIRAMATE [MI]", "stdName": "TOPIRAMATE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "494c2191-ca51-4591-8735-4183945e10e3" ], "display_name": false }, { "uuid": "d1f383df-aa2a-41fa-8aa1-5d17781fdc20", "name": "TOPIRAMATE [ORANGE BOOK]", "stdName": "TOPIRAMATE [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "338d2b97-f9ac-4a7f-a848-3fc4546a4084" ], "display_name": false }, { "uuid": "1a8be793-b060-4b22-a20f-eafa762a13d0", "name": "TOPIRAMATE [USAN]", "stdName": "TOPIRAMATE [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "387ebfff-7711-430c-b34c-934eb3e01a41" ], "display_name": false }, { "uuid": "ba4e3d6d-bd84-26a9-7bf0-3a24774d2b79", "name": "TOPIRAMATE [USP IMPURITY]", "stdName": "TOPIRAMATE [USP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "85ec5475-9ff8-4cf3-b4fc-0ca288e87dbc" ], "display_name": false }, { "uuid": "06ca2ae7-28d6-61f5-eaba-585dcebf75d6", "name": "TOPIRAMATE [USP MONOGRAPH]", "stdName": "TOPIRAMATE [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ec60c919-0053-5cac-76af-31fb6233a0c6" ], "display_name": false }, { "uuid": "00747a09-0b78-4cd3-b441-100898331d09", "name": "TOPIRAMATE [USP-RS]", "stdName": "TOPIRAMATE [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "54dceda7-569f-4635-9916-fddc3585a2df" ], "display_name": false }, { "uuid": "4c293191-45ce-425a-8802-bd8af389cada", "name": "TOPIRAMATE [VANDF]", "stdName": "TOPIRAMATE [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "174deea3-431a-4b11-bb07-4fdde6cae2ae" ], "display_name": false }, { "uuid": "10a05f85-386d-4bd3-89d3-34843e27851d", "name": "TOPOMAX", "stdName": "TOPOMAX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "0d72174d-2a54-47f5-be14-80aff6291b21", "name": "TPM", "stdName": "TPM", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "54bc4452-6fa8-4383-baf0-6b174a64347e" ], "display_name": false }, { "uuid": "369da4d7-70b2-f9cf-8038-bfffc87d983c", "name": "Topiramate [WHO-DD]", "stdName": "TOPIRAMATE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e010726c-a5c4-41c9-6863-073c65692bf3" ], "display_name": false }, { "uuid": "036a6ac6-1f5e-41ce-968f-b0507251a45a", "name": "USL-255", "stdName": "USL-255", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "a1789411-9790-4e69-bf53-d789d0555faf" ], "display_name": false }, { "uuid": "8e2d58d0-e83a-4d08-8c05-07216a3876fa", "name": "USL255", "stdName": "USL255", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "a1789411-9790-4e69-bf53-d789d0555faf" ], "display_name": false }, { "uuid": "a79b57b2-d837-44c4-aa3d-eaac2623409e", "name": "topiramate [INN]", "stdName": "TOPIRAMATE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c74d1930-eac6-45cc-98f2-003ae64b979f" ], "display_name": false } ], "properties": [ { "uuid": "62e5110d-0eb5-4360-8a5d-1bafd784ba42", "name": "Biological Half-life", "value": { "uuid": "aa65fe17-54f7-4e40-aa06-9da60d0a0ba5", "average": 21, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "1ec019fc-34d2-c0e6-e9b9-2efaacf4230d" ] }, { "uuid": "c3ddb3d7-59bc-4c25-bba7-99fbbba1f697", "name": "Tmax", "value": { "uuid": "2d6e6315-1591-447a-83d7-f5602b2617da", "average": 2, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC" } ] } ] }